- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07723768
Neuromuscular and Structural Effects of Using Stretching During the Recovery Phase Between Sets of Upper and Lower-body Strength Training
Efectos Neuromusculares y Estructurales de la utilización de Estiramientos en la Fase de recuperación Entre Series de Entrenamiento de la Fuerza de Los Miembros Superiores e Inferiores
Studieoversigt
Status
Betingelser
Intervention / Behandling
- Andet: Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
- Andet: Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
- Andet: Neuromuscular and structural effects of using NOT stretching during the recovery phase between sets of upper and lower-body strength training
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Madrid
-
Villaviciosa de Odón, Madrid, Spanien
- Edificio D
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
Male or female adults aged 18-30 years. Apparently healthy, with no medical conditions that contraindicate participation in resistance training.
A minimum of 6 consecutive months of resistance training experience. Regular resistance training participation of at least three sessions per week during the previous 6 months.
Previous experience performing the back squat and bench press exercises with correct technique.
Ability to perform maximal intended concentric velocity during resistance exercises.
Willingness to refrain from vigorous physical activity during the 24 hours preceding each testing and training session.
Ability and willingness to comply with all study procedures. Provision of written informed consent.
Exclusion Criteria:
Current musculoskeletal injury affecting the upper or lower limbs that limits participation in resistance training or testing.
Acute or chronic pain that is aggravated by the study exercises. Cardiovascular, neurological, metabolic, or other medical conditions that contraindicate vigorous physical exercise.
Current participation in another structured intervention study or clinical trial.
Inability to attend the scheduled assessments or training sessions. Failure to comply with the study protocol or training requirements. Withdrawal of informed consent at any stage of the study. Occurrence of an adverse event during the intervention that prevents continued participation.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Agonists stretching
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using AGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Andre navne:
|
|
Aktiv komparator: Antagonists stretching
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using ANTAGONISTS stretching during the recovery phase between sets of upper and lower-body strength training
Andre navne:
|
|
Placebo komparator: Control
Neuromuscular and structural effects of NOT using stretching during the recovery phase between sets of upper and lower-body strength training
|
Neuromuscular and structural effects of using NOT stretching during the recovery phase between sets of upper and lower-body strength training
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Acute resistance-training performance: total number of repetitions
Tidsramme: First intervention session (Week 1), across the four training sets.
|
Total number of repetitions completed across four sets of bench press and back squat during the first intervention session.
Participants will perform each set to momentary muscular failure at maximal intended concentric velocity, using individualized absolute loads corresponding to 75% of the estimated one-repetition maximum (1RM) for the bench press and 80% of the estimated 1RM for the back squat.
Repetitions completed in each set and total repetitions per exercise will be recorded to compare the immediate effects of agonist stretching, antagonist stretching, and no stretching.
|
First intervention session (Week 1), across the four training sets.
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 2024-495
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .